Dylan W. de Lange

Papers

Total Citations

H-Index

About

Dylan W. de Lange is a distinguished intensivist and clinical researcher whose work has profoundly shaped the understanding and management of critically ill patients, particularly those with severe infections and organ dysfunction. His research spans the intersections of critical care nephrology, infectious diseases in the ICU, and the epidemiology of acute kidney injury (AKI). De Lange is widely recognized for his contributions to the "Getting it right first time" philosophy in antimicrobial stewardship, emphasizing the critical importance of early, appropriate therapy in septic patients. His landmark studies on the timing and dosing of antibiotics in critically ill populations have influenced international guidelines, while his work on AKI has illuminated the long-term outcomes and risk stratification for patients requiring renal replacement therapy. With over 5,000 citations, his research is among the most influential in European intensive care medicine. Notably, he has been a leading investigator in large multinational collaborations, including the EPIC and SOAP studies, and has served as a key figure in the European Society of Intensive Care Medicine. His case-based teaching, exemplified by his detailed report on *Candida* peritonitis, demonstrates his commitment to translating complex clinical dilemmas into actionable insights for bedside clinicians.